| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/16/2013 | WO2013043878A3 Alternative splicing variants of genes associated with prostate cancer risk and survival |
| 05/16/2013 | WO2012065166A3 Dominant negative mutant kip-related proteins (krp) in zea mays and methods of their use |
| 05/16/2013 | WO2011133876A3 Oligonucleotides comprising acyclic and abasic nucleosides and analogs |
| 05/16/2013 | US20130125259 Rna interference mediating small rna molecules |
| 05/16/2013 | US20130123486 Photogenerated reagents |
| 05/16/2013 | US20130123483 Method and device for optimizing a nucelotide sequence for the purpose of expression in a protein |
| 05/16/2013 | US20130123482 Nucleotide and/or oligonucleotide and preparation process thereof |
| 05/16/2013 | US20130123481 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| 05/16/2013 | US20130123480 Multicomponent Nucleic Acid Enzymes And Methods For Their Use |
| 05/16/2013 | US20130123479 Soluble TNF Receptors and Their Use in Treatment of Disease |
| 05/16/2013 | US20130123478 Methods of preparing targeted aptamer prodrugs |
| 05/16/2013 | US20130123350 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO c-MET AND USE THEREOF |
| 05/16/2013 | US20130123342 Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna |
| 05/16/2013 | US20130123334 Novel sirna structures |
| 05/16/2013 | US20130123331 Modulation of diacylglycerol acyltransferase 2 expression |
| 05/16/2013 | US20130123129 Use of dnazymes for analysis of an rna sample |
| 05/16/2013 | US20130123119 Detection of food threat agents and food-borne pathogens |
| 05/16/2013 | US20130122569 Expression of Granular Starch Hydrolyzing Enzymes in Trichoderma and Process for Producing Glucose from Granular Starch Sustrates |
| 05/16/2013 | US20130122507 Nucleic Acid Amplification Using A Reversibly Modified Oligonucleotide |
| 05/16/2013 | US20130122493 Detection of neighboring variants |
| 05/16/2013 | US20130121996 Novel Complex Mutations in the Epidermal Growth Factor Receptor Kinase Domain |
| 05/16/2013 | DE69132920C5 Methode zur Herstellung von filamentösen, antikörper-präsentierenden Bakteriophagenpartikeln durch Verwendung von Phagemiden und die daduch hergestellten Bakteriophagenpartikel Method for the production of filamentous bacteriophage particles by antibody-presenting use of phagemids and the bacteriophage produced Daduchus |
| 05/16/2013 | DE4321904B4 Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen A process for chromatographic purification and separation of Nucleinsäuregemischen |
| 05/16/2013 | DE102011055247A1 Multianalyt-Reportersystem Multianalyt reporter system |
| 05/16/2013 | CA2855362A1 Compounds for the modulation of beta-catenin expression and uses thereof |
| 05/15/2013 | EP2592155A2 EGFR mutations |
| 05/15/2013 | CN103109183A Chronic lymphocytic leukemia modeled in mouse by targeted mir-29 expression |
| 05/15/2013 | CN103108642A Rna interference in dermal and fibrotic indications |
| 05/15/2013 | CN103102378A Method for extracting nucleic acid from bee pollen and purifying |
| 05/14/2013 | US8440883 Soybean cultivar S100004 |
| 05/14/2013 | US8440816 Branched polymers |
| 05/14/2013 | US8440811 DNA nanostructures that promote cell-cell interaction and use thereof |
| 05/14/2013 | US8440810 Riboswitches, methods for their use, and compositions for use with riboswitches |
| 05/14/2013 | US8440809 RNA antagonists targeting Hsp27 |
| 05/14/2013 | US8440808 Nucleic acid fragments and specific detection method by molecular identification of different bacteria species of the genus Acinetobacter |
| 05/14/2013 | US8440807 A34 and A33-like 3 DNA protein, antibodies thereto and methods of treatment using same |
| 05/14/2013 | US8440806 Humanized anti-CD4 antibody with immunosuppressive properties |
| 05/14/2013 | US8440805 Algal desaturases |
| 05/14/2013 | US8440804 Polypeptides having modulatory effects on cells |
| 05/14/2013 | US8440803 Tetrahydropyran nucleic acid analogs |
| 05/14/2013 | US8440802 CRH and POMC effects on animal growth |
| 05/14/2013 | US8440801 Aptamer against IL-17 and use thereof |
| 05/14/2013 | US8440788 N-terminal VDAC variants and uses thereof |
| 05/14/2013 | US8440637 Combination treatment for the treatment of hepatitis C virus infection |
| 05/14/2013 | US8440635 Oligonucleotide conjugates |
| 05/14/2013 | US8440451 Genetically modified yeast species, and fermentation processes using genetically modified yeast |
| 05/14/2013 | US8440449 Transformed Saccharomyces cerevisiae engineered for xylose utilization |
| 05/14/2013 | US8440444 Hybrid enzymes |
| 05/14/2013 | US8440436 Production of itaconic acid |
| 05/14/2013 | US8440435 Method for reducing 1,2-diglyceride content of an edible oil |
| 05/14/2013 | US8440433 Corynebacterium glutamicum enhanced expression of moaA gene encoding molybdenum cofactor biosynthesis enzyme A and method for producing L-lysine using the same |
| 05/14/2013 | US8440430 Modified dicer polypeptide and methods of use thereof |
| 05/14/2013 | US8440429 Method for detecting the presence of a nucleic acid in a sample |
| 05/14/2013 | US8440425 Method of preparing a biological specimen slide |
| 05/14/2013 | US8440401 Methods and compositions for DNA manipulation |
| 05/14/2013 | US8440399 Dark quenchers for donor-acceptor energy transfer |
| 05/14/2013 | US8440396 Using heat resistant polymerase to identify genomic variance associated with aberrant cell proliferation; treating and diagnosing tumor disorders |
| 05/14/2013 | US8440395 Methods of detecting and treating colon disorders |
| 05/14/2013 | US8440205 Streptococcal C5A peptidase vaccine |
| 05/14/2013 | US8440204 Subtype of Closteridium botulinum neurotoxin type A and uses thereof |
| 05/14/2013 | US8440201 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 05/14/2013 | US8440184 Compositions of engineered human arginases and methods for treating cancer |
| 05/14/2013 | CA2521130C Acyl-phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis |
| 05/14/2013 | CA2509827C A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome |
| 05/14/2013 | CA2455915C Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 05/10/2013 | WO2013067492A1 Isolated b7-h4 specific compositions and methods of use thereof |
| 05/10/2013 | WO2013067328A1 Transgenic pig models of cystic fibrosis |
| 05/10/2013 | WO2013067048A1 Materials and methods related to mir-221 and hepatocellular carcinoma |
| 05/10/2013 | WO2013066144A1 Markers for ganoderma disease diagnosis and a use of thereof |
| 05/10/2013 | WO2013036465A3 A conditional replicating cytomegalovirus as a vaccine for cmv |
| 05/10/2013 | WO2013033369A3 Engineered plant biomass for biodiesel and bioethanol production |
| 05/10/2013 | WO2013033165A3 Compositions, kits and methods for treating obesity, diabetes and hyperglycemia |
| 05/09/2013 | US20130116420 5' modified nucleosides and oligomeric compounds prepared therefrom |
| 05/09/2013 | US20130116419 Post-synthetic chemical modification of rna at the 2'-position of the ribose ring via "click" chemistry |
| 05/09/2013 | US20130116417 Methods for the Development of Vaccines Based on Oligosaccharide-Oligonucleotide Conjugates |
| 05/09/2013 | US20130116415 Fluorescence quenching azo dyes, their methods of preparation and use |
| 05/09/2013 | US20130116309 Oligomeric compounds for the modulation of hif-1a expression |
| 05/09/2013 | US20130115718 Carrier Carrying Identifying Information for Identifying an Identification Subject and Use Thereof |
| 05/09/2013 | US20130115614 Method for detecting and quantifying endogenous wheat dna sequence |
| 05/09/2013 | US20130115605 Method for preparative production of long nucleic acids by pcr |
| 05/09/2013 | US20130115603 Nucleotide repeat expansion-associated polypeptides and uses thereof |
| 05/09/2013 | US20130115590 Materials and method for immobilizing, isolating, and concentrating cells using carboxylated surfaces |
| 05/09/2013 | US20130115299 Method for inhibiting cancer stem cell like properties and chemoradioresistant properties of cancer or tumor cells with microrna145 |
| 05/09/2013 | US20130115215 Domain insertion immunoglobulin |
| 05/08/2013 | EP2589660A1 Compositions and methods for inhibiting expression of a gene from the Ebola |
| 05/08/2013 | EP2589602A2 Development of dengue virus vaccine components |
| 05/08/2013 | EP2588487A1 A new method of using n-thio compounds for oligonucleotide synthesis |
| 05/08/2013 | CN103097533A Y-probe and variation thereof, and DNA microarray, kit, and gene analysis method using the Y-probe and the variation thereof |
| 05/08/2013 | CN101194015B Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 05/07/2013 | US8436164 Aptamer therapeutics useful in the treatment of complement-related disorders |
| 05/07/2013 | US8436163 Splice-region antisense composition and method |
| 05/07/2013 | US8436162 Arabidopsis derived promoters for regulation of plant expression |
| 05/07/2013 | US8436161 Chimeric promoters comprising a rice actin 1 promoter and 35S enhancer for use in plants |
| 05/07/2013 | US8436160 Isolated DNA fragment of the SPARC human promoter and its use for driving the expression of an heterologous gene in tumor cells |
| 05/07/2013 | US8436158 Antibodies to IL-6 and their uses |
| 05/07/2013 | US8436144 Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders |
| 05/07/2013 | US8436142 Processing of recombinant human G-CSF precursor |
| 05/07/2013 | US8436137 Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide |
| 05/07/2013 | US8435960 Devices for improved wound management |
| 05/07/2013 | US8435783 Plant artificial chromosome platforms via telomere truncation |